MedTrace Logo

Therapeutic Effect of Surgical Debulking of Metastatic Lymph Nodes in Cervical Cancer Stage IIICr

NCT05421650 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2025-04-09

No results posted yet for this study

Summary

This study is a prospective, multicenter and randomized clinical trial (DEBULK trial) to determine the therapeutic effect of surgical debulking of bulky or multiple lymph nodes before concurrent chemoradiation therapy (CCRT) in cervical cancer stage IIICr.

Conditions

Interventions

OTHER

CCRT

CCRT

PROCEDURE

Surgical debulking of lymph nodes + CCRT

Surgical debulking of lymph nodes + CCRT

Sponsors & Collaborators

  • Korean Gynecologic Oncology Group

    collaborator OTHER

  • CHA University

    lead OTHER

Principal Investigators

  • Ju-Won Roh · CHA University Ilsan Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-01
Primary Completion
2030-12-31
Completion
2030-12-31

Countries

  • India
  • Italy
  • Romania
  • South Korea
  • Vietnam

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05421650 on ClinicalTrials.gov